Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

- PMLiVE

Amgen, Servier heart failure drug clears trial hurdle

Drug could be a blockbuster - if it hits key endpoints

- PMLiVE

Is Orkambi deal close? Vertex meets again today with NHS England

Campaigners hopes rise after three year wait

- PMLiVE

NHS needs £900m a year to avoid crippling staff shortages

Report predicts nurse shortage will triple to over 100,000 within the next 10 years

Leading Edge, a Lucid Group company, strengthens its senior client services team

Leading Edge, a Lucid Group company, is delighted to announce the appointment of its new Lead Client Partnership Director, Frances O’Connor.Frances is an experienced strategic healthcare communicator with expertise in...

Lucid Group Communications Limited

Quick Change

What bird feathers can teach us about adapting to the market

From Cowgirl to Medical Writer – How did that happen?

Amy Jackson, Editorial Director, Lucid Group discusses her unlikely path into Medical Communications.

Lucid Group Communications Limited

- PMLiVE

Pfizer hedges bets on gene therapy deal

Company not splashing out like Roche's Spark purchase

- PMLiVE

Sage’s postpartum depression treatment Zulresso gains US approval

First approval of its kind

Brain power: fresh approaches to Alzheimer’s drug discovery

New alliances are learning from past mistakes and breaking down research barriers

- PMLiVE

Urovant slips on phase 3 incontinence drug data

Underwhelming results send shares down

- PMLiVE

Roche, AbbVie hit by clinical hold for Venclexta in myeloma

Safety concerns could hit blockbuster expectations

Bristol Myers Squibb logo

BMS defends Celgene buyout ahead of shareholder vote

BMS battles for hearts and minds before shareholder vote

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links